MD vs UHS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 19, 2026

MD

58.6
AI Score
VS
MD Wins

UHS

58.2
AI Score

Investment Advisor Scores

MD

59score
Recommendation
HOLD

UHS

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MD UHS Winner
Net Income 29.57M 1.49B UHS
Operating Income 41.66M 1.99B UHS
ROE 3.4% 20.5% UHS
ROA 1.4% 9.6% UHS
Total Assets 2.07B 15.53B UHS
Cash 205.78M 137.80M MD
Debt/Equity 0.70 0.66 UHS
Current Ratio 1.33 1.05 MD

Relative Price Performance (Last 90 Days)

MD 1M: +1.4% · 3M: +17.8% UHS 1M: +11.9% · 3M: +0.1%

Current Technical Phase

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.9% over 20 days), RSI 57

RSI (14): 57.0 · Price: $26.51

UHS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 65.1 · Price: $168.44

Fundamentals Snapshot

Metric MD UHS
Market Cap
Forward P/E 11.3 6.5
Trailing P/E 12.7 6.8
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.4%
Operating Margin 0.1% 0.1%
EPS 2.12 24.79
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.